Literature DB >> 8842564

AT1 receptor density changes during development of hypertension in hyperinsulinemic rats.

S N Iyer1, M K Raizada, M J Katovich.   

Abstract

In a previous study we showed that the renin-angiotensin system (RAS) plays a role in the etiology of fructose-induced hypertension. To our knowledge, no previous study has evaluated changes in angiotensin II (Ang II) type I receptor (AT1) density in fructose-fed rats that are insulin resistant and hypertensive. The purpose of this study was to determine the changes in plasma Ang II and AT1 density associated with the elevation of blood pressure in fructose-treated rats. Male Sprague-Dawley rats were divided into two groups and were fed either normal rat chow or a 60% fructose-enriched diet for four weeks. Plasma Ang II and serum insulin levels of the fructose-treated rats were significantly elevated (p < 0.01) by the end of the second week of fructose treatment. Plasma Ang II levels of the fructose-fed rats returned to basal levels by the end of the fourth week of dietary treatment, whereas the serum insulin levels consistently remained elevated. Blood pressure was significantly elevated in the fructose-fed rats within two weeks of fructose treatment. Elevation of blood pressure was associated with left ventricular hypertrophy. Furthermore, there was a significant increase in AT1 receptor density in the ventricles and a significant decrease in AT1 receptor density in the aortas of fructose-fed rats at the end of fourth week. There were no significant changes in receptor density in the hypothalami or adrenal glands of fructose-treated rats. These results suggest that chronic fructose treatment activates the renin-angiotensin system, which is manifested by an increase in plasma Ang II, elevation of blood pressure, cardiac hypertrophy, and changes in AT1 receptor density.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8842564     DOI: 10.3109/10641969609081781

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  7 in total

Review 1.  Vascular signaling pathways in the metabolic syndrome.

Authors:  Hiromi Rakugi; Kei Kamide; Toshio Ogihara
Journal:  Curr Hypertens Rep       Date:  2002-04       Impact factor: 5.369

2.  Early pre-diabetic state alters adaptation of myocardial glucose metabolism during ischemia in rats.

Authors:  Sandrine Morel; Corinne Berthonneche; Stéphane Tanguy; Marie-Claire Toufektsian; Pascale Perret; Catherine Ghezzi; Joël de Leiris; François Boucher
Journal:  Mol Cell Biochem       Date:  2005-04       Impact factor: 3.396

3.  Cardiovascular interactions between losartan and fructose in mice.

Authors:  Danielle Senador; Mary Key; K Bridget Brosnihan; Maria Claudia Irigoyen; Khalid M Elased; Mariana Morris
Journal:  J Cardiovasc Pharmacol Ther       Date:  2009-12-07       Impact factor: 2.457

4.  The contribution of α1B-adrenoceptor subtype in the renal vasculature of fructose-fed Sprague-Dawley rats.

Authors:  Mohammed H Abdulla; Munavvar A Sattar; Nor A Abdullah; Md Abdul Hye Khan; Kolla R L Anand Swarup; Edward J Johns
Journal:  Eur J Nutr       Date:  2010-09-30       Impact factor: 5.614

Review 5.  The fructose-fed rat: a review on the mechanisms of fructose-induced insulin resistance and hypertension.

Authors:  Linda T Tran; Violet G Yuen; John H McNeill
Journal:  Mol Cell Biochem       Date:  2009-06-18       Impact factor: 3.396

6.  Role of the Renin-Angiotensin system and aldosterone on cardiometabolic syndrome.

Authors:  P Stiefel; A J Vallejo-Vaz; S García Morillo; J Villar
Journal:  Int J Hypertens       Date:  2011-06-23       Impact factor: 2.420

7.  Novel 18F-Labeled PET Imaging Agent FV45 Targeting the Renin-Angiotensin System.

Authors:  Xinyu Chen; Mitsuru Hirano; Rudolf A Werner; Michael Decker; Takahiro Higuchi
Journal:  ACS Omega       Date:  2018-09-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.